- Home
- BRT vs DRTS Comparison
BRT vs DRTS Comparison
Compare BRT & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRT
- DRTS
- Stock Information
- Founded
- BRT 1972
- DRTS 2015
- Country
- BRT United States
- DRTS Israel
- Employees
- BRT N/A
- DRTS N/A
- Industry
- BRT Real Estate Investment Trusts
- DRTS Medical/Dental Instruments
- Sector
- BRT Real Estate
- DRTS Health Care
- Exchange
- BRT Nasdaq
- DRTS Nasdaq
- Market Cap
- BRT 288.5M
- DRTS 274.0M
- IPO Year
- BRT N/A
- DRTS N/A
- Fundamental
- Price
- BRT $15.65
- DRTS $3.06
- Analyst Decision
- BRT Strong Buy
- DRTS Strong Buy
- Analyst Count
- BRT 1
- DRTS 2
- Target Price
- BRT $21.00
- DRTS $8.00
- AVG Volume (30 Days)
- BRT 30.8K
- DRTS 41.6K
- Earning Date
- BRT 08-05-2025
- DRTS 08-13-2025
- Dividend Yield
- BRT 6.41%
- DRTS N/A
- EPS Growth
- BRT N/A
- DRTS N/A
- EPS
- BRT N/A
- DRTS N/A
- Revenue
- BRT $98,162,000.00
- DRTS N/A
- Revenue This Year
- BRT $0.36
- DRTS N/A
- Revenue Next Year
- BRT $5.65
- DRTS N/A
- P/E Ratio
- BRT N/A
- DRTS N/A
- Revenue Growth
- BRT 2.71
- DRTS N/A
- 52 Week Low
- BRT $14.61
- DRTS $1.93
- 52 Week High
- BRT $20.22
- DRTS $4.39
- Technical
- Relative Strength Index (RSI)
- BRT 49.03
- DRTS 49.92
- Support Level
- BRT $15.25
- DRTS $2.95
- Resistance Level
- BRT $16.00
- DRTS $3.15
- Average True Range (ATR)
- BRT 0.35
- DRTS 0.14
- MACD
- BRT 0.01
- DRTS -0.02
- Stochastic Oscillator
- BRT 48.11
- DRTS 27.50
About BRT BRT Apartments Corp. (MD)
BRT Apartments Corp is a real estate investment trust company. The company is focused on the ownership, operation, and development of multi-family properties. BRT also owns and operates other real estate assets. All of the Company's assets are comprised of multi-family real estate assets generally leased to tenants on a one-year basis.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.